About Singular Bio
Singular Bio is a company based in San Francisco (United States) founded in 2012 by Hywel Jones was acquired by Invitae in June 2019. Singular Bio has raised $6.58 million across 2 funding rounds from investors including Invitae and The Vertical Group. Singular Bio operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Macrogen and Beikang Medical, among others.
- Headquarter San Francisco, United States
- Founders Hywel Jones
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Singular Bio
Singular Bio has successfully raised a total of $6.58M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.58 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Singular Bio
Singular Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Invitae and The Vertical Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in early and late-stage US companies are made.
|
Locked | Locked | Locked | |
|
Home-based genetic tests for detecting diseases are provided to individuals.
|
Locked | Locked | Locked |
Investor details for Singular Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Singular Bio
Investment portfolio details for Singular Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Singular Bio
Detailed financials for Singular Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Singular Bio Comparisons
Peer comparison for Singular Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Singular Bio
Singular Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Macrogen and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform for genetic disease analysis is provided.
|
Detailed competitors of Singular Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Singular Bio
Complete news archive for Singular Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Singular Bio
Singular Bio was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Singular Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Hywel Jones is the current CEO of Singular Bio. They have also founded this company.
Singular Bio is a funded company, having raised a total of $6.58M across 2 funding rounds to date.
Singular Bio was founded in 2012 in San Francisco, United States, within the biotechnology sector. A proprietary single molecule detection system is provided, where unique measurements are taken for each molecule through the integration of advanced optics, custom molecular biology, and chemistry. The screening platform is utilized for its user-friendly design, flexibility, and scalable throughput, supporting deployment in testing labs of varying sizes across different locations.
Singular Bio's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Singular Bio has 2 investors. Key investors include Invitae, and The Vertical Group.